フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
US multinational pharmaceutical firm Eli Lilly & Co said on Friday it plans to build a USD2.5 billion high-tech manuf ...
A diabetes drug has been authorised to help obese and overweight adults with weight management and loss, according to ...
The US Food and Drug Administration on Wednesday said it had approved Eli Lilly & Co's highly anticipated weight loss ...
Eli Lilly & Co on Thursday reported a rise in third-quarter revenue, helped by success for two of its diabetes drugs, ...
Eli Lilly & Co on Tuesday said both profit and revenue were up in the second quarter of 2023, while noting "key pipel ...
Eli Lilly & Co on Wednesday said the US Food & Drug Administration approved Jardiance as a treatment to lower blood s ...
Eli Lilly & Co on Thursday raised its annual guidance, despite suffering on a decline in revenue from Covid-19 antibo ...
Indianapolis, Indiana-based pharmaceutical firm - Says the US Food & Drug Administration has approved an expanded indi ...
US pharmaceutical firm Eli Lilly announced Wednesday it was cutting the cost of its most commonly prescribed insulin ...
Eli Lilly & Co on Thursday reported a dip in fourth quarter revenue amid foreign exchange headwinds, lower prices and ...
Eli Lilly & Co on Tuesday downgraded its full year guidance, despite posting an increase in both income and revenue, ...
Eli Lilly & Co lowered annual earnings guidance on Thursday, after it recognised a USD440 million charge in its secon ...
Eli Lilly & Co on Thursday reported increases in its fourth quarter revenue but noted a drop in its net income and ea ...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約